<div id="readability-page-1">Docusign (NASDAQ:DOCU - Get Free Report) had its price objective reduced by equities research analysts at JPMorgan Chase &amp; Co. from $78.00 to $65.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s price objective would suggest a potential upside of 36.13% from the company's current price.<ul><li>AI Is Separating Software Winners From Losers, 2 Experts Explain</li></ul>DOCU has been the subject of several other research reports. Wedbush reduced their price target on shares of Docusign from $85.00 to $75.00 and set a &#34;neutral&#34; rating for the company in a report on Friday, December 5th. Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Docusign in a research note on Tuesday, March 10th. BTIG Research reissued a &#34;buy&#34; rating and set a $70.00 price objective on shares of Docusign in a report on Wednesday. Cantor Fitzgerald reissued an &#34;outperform&#34; rating on shares of Docusign in a research note on Wednesday, December 17th. Finally, HSBC set a $53.00 target price on Docusign in a report on Friday, February 13th. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat, Docusign has a consensus rating of &#34;Hold&#34; and an average price target of $67.73.View Our Latest Research Report on Docusign<h2>Docusign Trading Up 0.4%</h2><ul><li>The Cloud Computing ETF Every Growth Investor Should Consider</li></ul>Shares of Docusign stock traded up $0.21 during trading on Wednesday, hitting $47.75. 7,088,167 shares of the stock traded hands, compared to its average volume of 4,843,658. The firm has a market cap of $9.56 billion, a P/E ratio of 33.32, a price-to-earnings-growth ratio of 2.04 and a beta of 1.03. Docusign has a 52-week low of $40.16 and a 52-week high of $94.67. The stock's fifty day simple moving average is $51.11 and its 200 day simple moving average is $64.46. Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.57% and a return on equity of 15.02%. The company had revenue of $836.86 million during the quarter, compared to analyst estimates of $828.23 million. During the same period in the prior year, the firm earned $0.86 earnings per share. The firm's revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, equities analysts expect that Docusign will post 1.17 EPS for the current year. <h2>Insider Activity</h2><ul><li>3 Stocks to Avoid as Software Sector Stumbles</li></ul>In other Docusign news, CRO Paula Hansen sold 6,000 shares of Docusign stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the transaction, the executive directly owned 68,970 shares of the company's stock, valued at approximately $4,624,438.50. The trade was a 8.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 26,250 shares of the company's stock in a transaction on Friday, January 9th. The stock was sold at an average price of $69.60, for a total value of $1,827,000.00. Following the transaction, the chief executive officer directly owned 142,261 shares in the company, valued at approximately $9,901,365.60. The trade was a 15.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 51,477 shares of company stock valued at $3,521,607 in the last ninety days. 1.66% of the stock is currently owned by insiders. <h2>Institutional Inflows and Outflows</h2>Several hedge funds have recently added to or reduced their stakes in DOCU. Vanguard Group Inc. boosted its holdings in Docusign by 1.1% in the third quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company's stock worth $1,558,986,000 after acquiring an additional 225,525 shares in the last quarter. State Street Corp grew its stake in shares of Docusign by 0.9% during the fourth quarter. State Street Corp now owns 8,193,805 shares of the company's stock worth $560,456,000 after acquiring an additional 77,008 shares during the last quarter. Capital World Investors increased its holdings in shares of Docusign by 38.1% during the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company's stock valued at $397,801,000 after acquiring an additional 1,603,900 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of Docusign by 1.6% during the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company's stock valued at $433,405,000 after acquiring an additional 86,560 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in Docusign by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company's stock worth $278,665,000 after purchasing an additional 18,873 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds. <h2>Key Docusign News</h2>Here are the key news stories impacting Docusign this week:<ul> <li>Positive Sentiment: Q4 beat and upbeat guidance — DocuSign reported Q4 adjusted EPS of $1.01 and revenue of $836.9M, topping consensus; management provided a slightly stronger-than-expected near‑term revenue outlook. This is the main catalyst for the intraday uptick. DocuSign Beats Q4</li> <li>Positive Sentiment: $2.0 billion buyback increase — The company expanded its share repurchase program by $2B, a significant capital return action that supports EPS and signals confidence from the board. PR Newswire Release</li> <li>Positive Sentiment: IAM/AI momentum — Management highlighted IAM customers generating &gt;$350M ARR and expanding AI partnerships, which investors view as durable upsell/retention levers beyond e‑signature. Earnings Call Transcript</li> <li>Neutral Sentiment: Longer‑term bull case surfaced in commentary — Some deep-dive pieces argue DOCU is oversold given improving margins and Rule-of-40 progress; useful for patient investors but may be less relevant to near‑term price action. Seeking Alpha Analysis</li> <li>Negative Sentiment: Multiple analyst price‑target cuts — Several firms trimmed targets this morning (RBC to $55, UBS to $54, Robert W. Baird to $55, Wells Fargo to $60, Citizens from $124→$86), reflecting caution on growth/profitability. These downgrades cap upside and explain mixed trader sentiment despite the beat. Benzinga: analyst moves</li> <li>Negative Sentiment: Analysts want faster revenue acceleration — Coverage notes that while execution and AI products look promising, many analysts are waiting for sustained 10%+ revenue growth; that expectation gap is driving the recent target cuts and volatility. MSN Article</li> </ul><h2>About Docusign</h2> (Get Free Report)DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage. DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.<h2>See Also</h2><ul><li>Five stocks we like better than Docusign</li></ul><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RE9DVQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RE9DVQ"/>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in Docusign Right Now?</h2>Before you consider Docusign, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

JPM-K

DOCU

JPM-D

JPMorgan Chase & Co. has lowered its price target for Docusign (NASDAQ:DOCU) from $78.00 to $65.00, maintaining a "neutral" rating. This suggests a potential upside of 36.13% from the current price of $47.75. Other analysts have also adjusted their targets, with a consensus rating of "Hold" and an average price target of $67.73. Docusign reported a quarterly EPS of $1.01, exceeding estimates, with revenue up 7.8% year-over-year. Insider trading activity has seen significant share sales by executives recently.

Market Beat

Defiance Daily Target 2X Long JPM ETF

iShares Expanded Tech Software Sector ETF

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

SPDR S&P Software

JPMorgan Chase

Docusign

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMorgan Chase & Co. Lowers Docusign (NASDAQ:DOCU) Price Target to $65.00